📢Focus issue of articles on the theme of metabolic alterations in heart failure to mark the start of the @Soc_HrtVasMetab meeting in Bordeaux⤵️
Our @COSTprogramme @EU_METAHEART CA22169 compiled a FOCUS ISSUE on METABOLIC ALTERATIONS in #heartfailure @NatRevCardiol. Read the editorial➡️rdcu.be/esyLu & 4 Reviews outlined in thread⬇️@escardio @Soc_HrtVasMetab @AHAScience @DGKardio @dzhk_germany @ISHR_ES @ISHR_NAS
Special thanks to the team of @NatRevCardiol, in particular Dr. Gregory Lim!
COST Action EU-METAHEART retweeted
All 4 reviews are OPEN ACCESS for 1 month at nature.com/nrcardio/. Special thanks to the team of @NatRevCardiol, in particular Dr. Gregory Lim! Please also visit our website cost-metaheart.eu/ & become member at cost.eu/actions/CA22169/. @sfb1525 @Uni_WUE @DZHI_Wuerzburg
COST Action EU-METAHEART retweeted
Finally, in review #4 @dunjaaks @simon_sedej @PaillardMel @KatrinStreckf @EdoardoBertero @JeremyFauconni1 et al discuss how the imbalance between mechanical load and mitochondrial ATP supply induces a redox mismatch that drives #heartfailure progression. nature.com/articles/s41569-0…
COST Action EU-METAHEART retweeted
In review #3, @G_Vilahur @GhigoAlessandra et al. discuss how the interplay between #inflammation & #metabolism drives #heartfailure progression across etiologies & along the EF spectrum. In loving memory of Ioanna Andreadou academic.oup.com/eurheartj/a….
nature.com/articles/s41569-0…
COST Action EU-METAHEART retweeted
In article #2, @liberale_luca @PKleinbongard et al. review the central role of coronary &systemic vascular dysfunction in #heartfailure (pEF&rEF), providing a mechanistic framework for therapies targeting the vasculature in different HF phenotypes. nature.com/articles/s41569-0…
COST Action EU-METAHEART retweeted
In review #1, Mathias Mericskay et al. discuss dysregulated substrate & intermediary metabolism and its role for post-translational modifications in #heartfailure (HFpEF&rEF). W/contr by @gabrieleschiat1 @Heatherlab_ox @BertrandLuc_ky @AnjaKarlstaedt
nature.com/articles/s41569-0…
📢📢📢3rd meeting of the management committee (MC3) of our @EU_METAHEART COST Action on March 19 and 20, 2025 ➡️➡️➡️ please join online
👍Program and how to join online: cost-metaheart.eu/news/progr…
📣📣📣A comprehensive overview on the multifaceted mechanisms driving cardiac amyloidosis led by @EU_METAHEART Core members
@liberale_luca @ChristophMaack @PKleinbongard
⏩link.springer.com/article/10…
📢New Research Highlight from @EU_METAHEART consortium
“Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage”
by Panagiota-Efstathia Nicolau, Ioanna Andreadou
& collaborators⤵️
sciencedirect.com/science/ar…
🔊🔊🔊Call for Short-term scientific mission (STSM) open from Monday, November 25th until December 9th, 2024
🎓You are a Young Research Innovator? You want to visit another lab from @EU_METAHEART?
📝Apply for a grant up to 2k€
More info: cost-metaheart.eu/news/call-…
📢📢📢SAVE THE DATE!!!
WG2 webinar on December 10th 2024 – 5PM CET
on microvascular dysfunction in Takotsubo & HF, & sex-specific differences
To join:
Zoom meeting-ID: 912 1197 3978
Password: 991198
more info⤵️⤵️⤵️⤵️
The Medical University of Graz (Austria) is opening a position of Tenure Track Professor of Sex and Gender-dependent Mechanisms in the Pathophysiology of Cardio-metabolic Disease
Application via their online job portal
medunigraz.at/en/job-opening…
Application deadline: 7 November 2024
⚠️⚠️📢📢IMPORTANT NEWS!!!
our Website is now ON!!! Please take a look⤵️
EU-METAHEART | COST Action CA22169 – EUropean network to tackle METAbolic alterations in HEART failure (cost-metaheart.eu)
to find out news, job opportunities & more💡🔍
📃📣 📣📣September news!
➡️Great success for our 1st Training School in Wurzburg on @OroborosI, Seahorse & @IonOptix with 18 students & postdocs
➡️ International conference with 4 awardees for their great presentation: Angeliki Dajou, Hualin Fan, Matus Miklovic & David Weissman
Lisa @Heatherlab_ox giving a nice overview on posttranslational modifications by metabolic intermediates in diabetes and other CV diseases @EU_METAHEART meeting. Much more in metabolism than just ATP! @gabrieleschiat1 @ISHR_ES @BasicResCardiol














